These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8418310)

  • 1. Opportunities "opening up" for gene therapy.
    Vanchieri C
    J Natl Cancer Inst; 1993 Jan; 85(2):90-1. PubMed ID: 8418310
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined zidovudine and interferon-alpha 2a therapy in children with acquired immune deficiency syndrome.
    Giovannini M; Zuccotti GV; Biasucci G; Locatelli V; Riva E
    J Int Med Res; 1992 Jun; 20(3):295-301. PubMed ID: 1397675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble recombinant CD4--a potential therapeutic agent for HIV infection.
    Rosenberg M; Bugelski PJ; Fong KL; Drutz DJ; Sweet RW; Webb DD
    Biotherapy; 1990; 2(2):107-18. PubMed ID: 2205260
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon ineffective for AIDS.
    Am Pharm; 1992 Aug; NS32(8):14. PubMed ID: 1524014
    [No Abstract]   [Full Text] [Related]  

  • 5. New roles for interferon-alpha?
    Dudjak LA
    Am J Nurs; 1992 Feb; 92(2):16. PubMed ID: 1739108
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gene transfer into non-dividing cells by a lentiviral vector].
    Miyake K; Shimada T
    Uirusu; 1997 Dec; 47(2):213-9. PubMed ID: 9545867
    [No Abstract]   [Full Text] [Related]  

  • 7. Gore Tex organoids and genetic drugs.
    Culliton BJ
    Science; 1989 Nov; 246(4931):747-9. PubMed ID: 2633774
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose interferon-alpha and HIV infection.
    Lancet; 1992 May; 339(8801):1106. PubMed ID: 1349115
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant alpha-2a interferon in HIV-associated myelodysplasia.
    Garavelli PL
    Haematologica; 1988; 73(6):547. PubMed ID: 3148520
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous gamma-globulin in infant acquired immunodeficiency syndrome.
    Calvelli TA; Rubinstein A
    Pediatr Infect Dis; 1986; 5(3 Suppl):S207-10. PubMed ID: 3086850
    [No Abstract]   [Full Text] [Related]  

  • 11. NIH plans trials of controversial AIDS drug.
    Anderson C
    Nature; 1992 Nov; 360(6399):8. PubMed ID: 1436079
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of HIV infection: perspectives].
    Monsuez JJ
    Pathol Biol (Paris); 1992 Jun; 40(6):609-20. PubMed ID: 1383913
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of immunoglobulins in AIDS].
    Accurso V; Mancuso S; Mitra ME; Caravello E; Abbadessa V; Cajozzo A
    Recenti Prog Med; 1990; 81(7-8):504-6. PubMed ID: 2247698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic evolution in immunization.
    Griffiths PD
    Rev Med Virol; 2015 May; 25(3):131-2. PubMed ID: 25855574
    [No Abstract]   [Full Text] [Related]  

  • 15. Kemron trial stopped.
    Highleyman L
    BETA; 1997 Sep; ():5. PubMed ID: 11364704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].
    Lopez Bran E; Aguilar R; Marron JA; Figueredo MA; Garcia Ruiz JM
    Med Cutan Ibero Lat Am; 1989; 17(4):269-73. PubMed ID: 2693866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientists changing therapy outlook for AIDS patients.
    Antoine FS
    J Natl Cancer Inst; 1990 Jun; 82(12):992-6. PubMed ID: 2348475
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical applications of colony-stimulating factors in acquired immunodeficiency syndrome.
    Scadden DT
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):33-7. PubMed ID: 1492232
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant alpha-2a interferon treatment in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC): clinical and immunological evaluation.
    Mezzaroma I; Avella A; Paganelli R; Ensoli B; d'Offizi G; Sirianni MC; Luzi G; Valdarchi C; Aiuti F
    Allergol Immunopathol (Madr); 1991; 19(5):201-7. PubMed ID: 1811417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
    Daar ES; Li XL; Moudgil T; Ho DD
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6574-8. PubMed ID: 2395859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.